BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia).

Direct comparative studies are needed of the safety and efficacy of drugs used to treat neuropathic pain.

The efficacy of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy has been established in several controlled clinical trials. [17,18,19] These trials ...

This type of pain can be severe and more difficult to treat. Nerve pain is typically treated with prescription-strength medications, but some over-the-counter products, primarily topical creams ...

AFA-281 is under clinical development by AfaSci and currently in Phase I for Neuropathic Pain (Neuralgia). According to GlobalData, Phase I drugs for Neuropathic Pain (Neuralgia) have a 76% phase ...

Medically reviewed by William Truswell, MD Hidradenitis suppurativa (HS) is a chronic (long-term) inflammatory skin condition ...

Vertex Pharmaceuticals said on Thursday its experimental non-opioid drug met the main goal of a mid-stage study but showed ...

Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) said it submitted an Investigational New Drug (IND) application to the FDA to start ...

A new study has found a potential breakthrough in the treatment of chronic pain and doesn't rely on addictive opiate ...

To transmit pain signals, nerve growth factor binds to a receptor ... relieved osteoarthritis pain better than placebo or other drugs, but because some patients experienced worsening joint damage ...